tirzepatide and bone loss GLP-1s Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle does tirzepatide cause osteoporosis Tirzepatide,

Mean age was 5610 years, BMI 33.06.3 kg/m 2 , HbA1c 8.00.7%, and diabetes duration 7.65.5 years, and individuals were on a stable dose of metformin (1,500 mg or maximum tolerated) with or without SGLT-2i

HGH is more commonly associated with water retention, insulin resistance , and organ growth at extreme doses

The most frequently reported include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation

Common side effects for both include nausea, diarrhea, vomiting, constipation, stomach pain, and fatigue

ISF induced gastric and intestinal distension, which increased circulating GLP-1 levels and activated a subset of vagal sensory neurons (Fig